Clinical Trials on Visual Acuity in New Zealand
Total 4428 results
-
Janssen Research & Development, LLCTerminatedHealthy | Hepatitis B, ChronicNew Zealand
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Route 92 Medical, Inc.CompletedAcute Ischemic StrokeNew Zealand
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Qilu Pharmaceutical Co., Ltd.Unknown
-
Gilead SciencesCompletedChronic Hepatitis CNew Zealand
-
Evolution Optiks LimitedCompletedAstigmatism | Visual Acuity | AnisometropiaUnited States
-
Novartis PharmaceuticalsTerminated
-
Gilead SciencesCompleted
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
Assembly BiosciencesCompletedChronic Hepatitis BNew Zealand
-
Enanta Pharmaceuticals, IncTerminatedChronic Hepatitis B Virus InfectionNew Zealand
-
Arbutus Biopharma CorporationRecruitingChronic Hepatitis bNew Zealand
-
Gilead SciencesCompleted
-
Vertex Pharmaceuticals IncorporatedCompletedHepatitis C | Chronic Hepatitis C | HCV | CHCNew Zealand
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Antipodean Pharmaceuticals, Inc.Completed
-
Arrowhead PharmaceuticalsTerminated
-
Assembly BiosciencesCompleted
-
Gilead SciencesCompletedChronic Hepatitis C InfectionNew Zealand
-
Novira Therapeutics, Inc.CompletedChronic Hepatitis BNew Zealand
-
Virion TherapeuticsRecruitingChronic Hepatitis BHong Kong, New Zealand
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedMucositis | Xerostomia | Radiation Toxicity | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Nasopharynx | Stage III Squamous Cell Carcinoma... and other conditionsUnited States, New Zealand
-
Aligos TherapeuticsTerminatedChronic Hepatitis BUnited Kingdom, New Zealand
-
National University Heart Centre, SingaporeAstraZenecaRecruitingAcute Coronary SyndromeAustralia, New Zealand, Singapore
-
NeuroActiva, Inc.Biomed Industries, Inc.UnknownCovid19 | SARS-CoV-2 | SARS-CoV Infection | SARS (Severe Acute Respiratory Syndrome)New Zealand, United States
-
Valneva Austria GmbHCompletedSARS-CoV-2 InfectionNew Zealand, Netherlands
-
NovartisNovartis PharmaceuticalsCompletedHepatitis BHong Kong, Singapore, New Zealand
-
Arrow TherapeuticsDDS, Dundee; David Mutimer, Birmingham; Ed Gane, ACS New ZealandTerminatedChronic Hepatitis CNew Zealand, United Kingdom
-
Kirby InstituteAbbVieCompletedHepatitis C, AcuteUnited Kingdom, Australia, New Zealand
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Poland, France
-
Hoffmann-La RocheCompletedHepatitis C, ChronicNew Zealand, Australia
-
Gilead SciencesCompletedChronic Hepatitis BUnited States, New Zealand
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Zealand University HospitalCompletedEndothelial Dysfunction | Acute CholecystitisDenmark
-
Soroka University Medical CenterEiger BioPharmaceuticalsActive, not recruitingHepatitis D, ChronicIsrael, New Zealand, Turkey
-
Hoffmann-La RocheTerminatedHepatitis B, ChronicHong Kong, Taiwan, New Zealand
-
Eiger BioPharmaceuticalsCompletedHepatitis D, ChronicIsrael, New Zealand, Pakistan
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Chronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Recurrent Disease | Recurrent Adult Acute Lymphoblastic Leukemia | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic... and other conditionsUnited States, Canada, New Zealand
-
Trek Therapeutics, PBCCompletedChronic Hepatitis C | Hepatitis C Genotype 1 | Hepatitis C (HCV) | Hepatitis C Viral InfectionUnited States, New Zealand
-
Arbutus Biopharma CorporationCompletedHepatitis B, ChronicAustralia, New Zealand
-
Syneos HealthF-star Therapeutics, Inc.CompletedHepatitis C InfectionAustralia, New Zealand
-
Kirby InstituteCompletedDAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) (DARE-C II)Hepatitis CAustralia, New Zealand
-
Unity Health TorontoRoche Pharma AGCompletedDyspnea | Acute Heart Failure | Shortness of BreathCanada, United States, New Zealand
-
Macfarlane Burnet Institute for Medical Research...St Vincent's Hospital MelbourneCompletedHepatitis CAustralia, New Zealand
-
AzurRx SASCompletedChronic Pancreatitis | Distal PancreatectomyAustralia, New Zealand, France
-
Gilead SciencesCompletedHCV InfectionUnited States, Germany, New Zealand
-
Edward J. HollandAlcon Research; Sirion Therapeutics, Inc.; Parsons Medical CommunicationsCompletedCorneal Edema | Cataracts | Visual Acuity Reduced Transiently | Retinal Structural Change, Deposit and DegenerationUnited States